NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

Oxaliplatin的中國市場:2021年∼2025年

Investigation Report on China's Oxaliplatin Market 2021-2025

出版商 China Research and Intelligence 商品編碼 1009414
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
Oxaliplatin的中國市場:2021年∼2025年 Investigation Report on China's Oxaliplatin Market 2021-2025
出版日期: 2021年06月04日內容資訊: 英文 50 Pages
簡介

中國市場中Oxaliplatin的銷售額,2016年∼2019年年年增加。由於COVID-19傳染病對醫療診斷、治療服務全體的影響,中國市場中Oxaliplatin的銷售額,2020年減少到11億6,500萬人民幣。中國市場中Oxaliplatin的銷售額的年複合成長率,2016年∼2020年是4.29%。

本報告提供中國的Oxaliplatin市場相關調查分析,COVID-19的影響,銷售額、銷售數量,價格,市場預測等相關的系統性資訊。

目錄

第1章 Oxaliplatin的相關概念

  • Oxaliplatin的適應症
  • 中國的Oxaliplatin的發展
  • 中國的Oxaliplatin的政府核准
  • COVID-19對中國的Oxaliplatin銷售的影響

第2章 中國的Oxaliplatin銷售

  • Oxaliplatin的銷售額
    • 總銷售額
    • 銷售額:各地區
  • Oxaliplatin銷售數量
    • 總銷售數量
    • 銷售數量:各地區
  • Oxaliplatin銷售:中國的各劑型
    • 注射
    • 其他劑型分析

第3章 中國的主要Oxaliplatin製造商分析

  • 主要的Oxaliplatin製造商市場佔有率分析
    • 市場佔有率:各銷售額
    • 市場佔有率:各銷售數量
  • Sanofi-Aventis France
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Shenzhen Neptunus Pharmaceutical Co., Ltd.
  • Cisen Pharmaceutical Co., Ltd.
  • Sichuan Meida Kangjiale Pharmaceutical Co., Ltd.

第4章 中國的各種製造商Oxaliplatin的價格

  • Sanofi-Aventis France (ELOXATIN)
  • Jiangsu Hengrui Medicine Co., Ltd. (Aiheng)
  • Shenzhen Neptunus Pharmaceutical Co., Ltd. (Aikebokang)
  • Cisen Pharmaceutical Co., Ltd. (Chenya)
  • Sichuan Meida Kangjiale Pharmaceutical Co.,Ltd. (Jialetongtai)

第5章 中國的Oxaliplatin市場預測

  • 中國的Oxaliplatin市場發展的影響要素
  • 市場規模的預測
  • 市場趨勢的預測
目錄
Product Code: 2106514

Oxaliplatin (OXA) is the third-generation platinum anti-tumor drug after cisplatin and carboplatin. Oxaliplatin was jointly developed by Sanofi and Debiopharm for the first-line treatment of metastatic colon cancer and the adjuvant treatment of stage III colon cancer after complete resection of the primary tumor. It was approved to enter the Chinese market in 1999. By the end of 2020, there are nearly 20 manufacturers in China's Oxaliplatin market of which Sanofi-Aventis France has the largest market share.

According to CRI's market research, the sales value of Oxaliplatin in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the COVID-19 epidemic on the hospital's overall diagnosis and treatment services, the sales value of Oxaliplatin in the Chinese market decreased to CNY1.165 billion in 2020. The CAGR of Oxaliplatin's sales value in the Chinese market from 2016 to 2020 was 4.29%.

CRI expects that Oxaliplatin sales will have a restorative growth in 2021-2025 as the alleviation of the COVID-19 epidemic. In 2020, the number of new colon cancer cases in China was 550,000, with an increase of 46.28% from 376,000 in 2018. Therefore, Oxaliplatin sales will increase from 2016 to 2020 with the increase in the number of colon cancer patients.

Topics Covered:

  • The impact of COVID-19 on China's Oxaliplatin market
  • Sales value of China's Oxaliplatin 2016-2020
  • Competitive landscape of China's Oxaliplatin market
  • Prices of Oxaliplatin in China
  • Prices of Oxaliplatin in China by regions and manufacturers
  • Analysis of factors affecting the development of China's Oxaliplatin market
  • Prospect of China's Oxaliplatin market from 2021 to 2025

Table of Contents

1 Relevant Concepts of Oxaliplatin

  • 1.1 Indications for Oxaliplatin
  • 1.2 Development of Oxaliplatin in China
  • 1.3 Governmental Approval of Oxaliplatin in China
  • 1.4 The Impact of COVID-19 on Oxaliplatin Sales in China

2 Sales of Oxaliplatin in China, 2016-2020

  • 2.1 Sales Value of Oxaliplatin
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Oxaliplatin
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Oxaliplatin by Dosage Form in China, 2016-2020
    • 2.3.1 Injection
    • 2.3.2 Analysis of Other Dosage Form

3 Analysis of Major Oxaliplatin Manufacturers in China in 2020

  • 3.1 Analysis of Market Share of Major Oxaliplatin Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 Sanofi-Aventis France
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of ELOXATIN (Sanofi-Aventis France's Oxaliplatin) in China
  • 3.3 Jiangsu Hengrui Medicine Co., Ltd.
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of Aiheng (Jiangsu Hengrui Medicine Co., Ltd.'s Oxaliplatin) in China
  • 3.4 Shenzhen Neptunus Pharmaceutical Co.,Ltd.
    • 3.4.1 Enterprise Profile
    • 3.4.2 Sales of Aikebokang (Shenzhen Neptunus Pharmaceutical Co.,Ltd.'s Oxaliplatin) in China
  • 3.5 Cisen Pharmaceutical Co., Ltd.
    • 3.5.1 Enterprise Profile
    • 3.5.2 Sales of Chenya (Cisen Pharmaceutical Co., Ltd.'s Oxaliplatin) in China
  • 3.6 Sichuan Meida Kangjiale Pharmaceutical Co.,Ltd.
    • 3.6.1 Enterprise Profile
    • 3.6.2 Sales of Jialetongtai (Sichuan Meida Kangjiale Pharmaceutical Co.,Ltd.'s Oxaliplatin) in China

4 Prices of Oxaliplatin for Different Manufacturers in China, 2020-2021

  • 4.1 Sanofi-Aventis France (ELOXATIN)
  • 4.2 Jiangsu Hengrui Medicine Co., Ltd. (Aiheng)
  • 4.3 Shenzhen Neptunus Pharmaceutical Co., Ltd. (Aikebokang)
  • 4.4 Cisen Pharmaceutical Co., Ltd. (Chenya)
  • 4.5 Sichuan Meida Kangjiale Pharmaceutical Co.,Ltd. (Jialetongtai)

5 Prospect of Chinese Oxaliplatin Market, 2021-2025

  • 5.1 Influential Factors of Chinese Oxaliplatin Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Oxaliplatin Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Oxaliplatin Injection Registration in China
  • Chart Sales Value of Oxaliplatin Injection over the World
  • Chart Sales Value of Oxaliplatin Injection in China, 2016-2020
  • Chart Sales Value of Oxaliplatin Injection in China by Region, 2016-2020
  • Chart Sales Volume of Oxaliplatin Injection in China, 2016-2020
  • Chart Sales Volume of Oxaliplatin Injection in China by Region, 2016-2020
  • Chart Market Share by Sales Value of Top Oxaliplatin Injection Manufacturers in China, 2016-2020
  • Chart Sales Value and Volume of ELOXATIN in China, 2016-2020
  • Chart Sales Value and Volume of Aiheng in China, 2016-2020
  • Chart Sales Value and Volume of Aikebokang in China, 2016-2020
  • Chart Sales Value and Volume of Chenya in China, 2016-2020
  • Chart Sales Value and Volume of Jialetongtai in China, 2016-2020
  • Chart Referential Prices of ELOXATIN in China by Region, 2020-2021
  • Chart Referential Prices of Aiheng in China by Region, 2020-2021
  • Chart Referential Prices of Aikebokang in China by Region, 2020-2021
  • Chart Referential Prices of Chenya in China by Region, 2020-2021
  • Chart Referential Prices of Jialetongtai in China by Region, 2020-2021
  • Chart Forecast on Sales Value of Oxaliplatin Injection in China, 2021-2025
  • Chart Forecast on Sales Volume of Oxaliplatin Injection in China, 2021-2025